ArticleCureus2025
Intralesional Alteplase as an Adjunct to Percutaneous Drainage for a Large Iliopsoas Muscle Hematoma in a Patient With Von Willebrand Disease: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present the case of a 32-year-old woman with type III von Willebrand disease who, after a chiropractic manipulation, developed a large iliopsoas muscle hematoma with femoral neuropathy. Given the lack of recombinant factor VIII at our institution, we opted for a minimally invasive, interdisciplinary approach. The patient was clinically stable and fully adherent to the proposed interdisciplinary management plan. A percutaneous drainage was placed and supplemented with intralesional alteplase irrigations, which allowed for a progressive reduction of the hematoma, resolution of the neuropathy, and the patient's complete recovery. The patient was discharged with minimal residual weakness, and at six weeks, imaging showed near-complete resolution of the collection and full return to daily activities. This case demonstrates the success of combining percutaneous drainage with fibrinolytic agents as an effective and safe alternative to conventional surgical management in patients with severe coagulopathies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.